TB
TCR Cure develops tumor immune cell therapy to enhance the body’s natural immune response against cancer cells. This approach aims to improve treatment outcomes for patients with various types of tumors by harnessing and modifying immune cells to target and destroy malignant cells more effectively.
Updated 3 months ago
Funding
$50M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- TCR Cure develops tumor immune cell therapy to enhance the body’s natural immune response against cancer cells. This approach aims to improve treatment outcomes for patients with various types of tumors by harnessing and modifying immune cells to target and destroy malignant cells more effectively.